A Review of Magnetic Particle Imaging and Perspectives on Neuroimaging

References

1. 1.↵
   2. Gleich B,
   3. Weizenecker J

   . Tomographic imaging using the nonlinear response of magnetic particles. Nature 2005;435:1214–17 doi:10.1038/nature03808 pmid:15988521

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Rahmer J,
   3. Gleich B,
   4. Weizenecker J, et al

   . 3D real-time magnetic particle imaging of cerebral blood flow in living mice. In: Proceedings of the International Society for Magnetic Resonance in Medicine, 18, 2010
3. 3.↵
   2. Ludewig P,
   3. Gdaniec N,
   4. Sedlacik J, et al

   . Magnetic particle imaging for real-time perfusion imaging in acute stroke. ACS Nano 2017;11:10480–88 doi:10.1021/acsnano.7b05784 pmid:28976180

   CrossRefPubMed
4. 4.↵
   2. Orendorff R,
   3. Keselman K,
   4. Conolly S

   . Quantitative cerebral blood flow and volume measurements by magnetic particle imaging. In: 13th European Molecular Imaging Meeting, March 20–23, 2018. San Sebastián, Spain
5. 5.↵
   2. Tomitaka A,
   3. Arami H,
   4. Gandhi S, et al

   . Lactoferrin conjugated iron oxide nanoparticles for targeting brain glioma cells in magnetic particle imaging. Nanoscale 2015;7:16890–98 doi:10.1039/C5NR02831K pmid:26412614

   CrossRefPubMed
6. 6.↵
   2. Fu A,
   3. Wilson RJ,
   4. Smith BR, et al

   . Fluorescent magnetic nanoparticles for magnetically enhanced cancer imaging and targeting in living subjects. ACS Nano 2012;6;6862–69 doi:10.1021/nn301670a pmid:22857784

   CrossRefPubMed
7. 7.↵
   2. Finas D,
   3. Baumann K,
   4. Sydow L, et al

   . Lymphatic tissue and superparamagnetic nanoparticles: magnetic particle imaging for detection and distribution in a breast cancer model. Biomed Tech 2013 Sep 7. [Epub ahead of print] doi:10.1515/bmt-2012-4158 pmid:24042920

   CrossRefPubMed
8. 8.↵
   2. Zheng B,
   3. von See MP,
   4. Yu E, et al

   . Quantitative magnetic particle imaging monitors the transplantation, biodistribution, and clearance of stem cells in vivo. Theranostic 2016;6:291–301 doi:10.7150/thno.13728 pmid:26909106

   CrossRefPubMed
9. 9.↵
   2. Song G,
   3. Chen M,
   4. Zhang Y, et al

   . Janus iron oxides @ semiconducting polymer nanoparticle tracer for cell tracking by magnetic particle imaging. Nano Lett 2018;18:182–89 doi:10.1021/acs.nanolett.7b03829 pmid:29232142

   CrossRefPubMed
10. 10.↵
    2. Goodwill PW,
    3. Lu K,
    4. Zheng B, et al

    . An x-space magnetic particle imaging scanner. Rev Sci Instrum 2012;83 doi:10.1063/1.3694534 pmid:22462930

    CrossRefPubMed
11. 11.↵
    2. Rahmer J,
    3. Weizenecker J,
    4. Gleich B, et al

    . Signal encoding in magnetic particle imaging: properties of the system function. BMC Med Imaging 2009;9:4 doi:10.1186/1471-2342-9-4 pmid:19335923

    CrossRefPubMed
12. 12.↵
    2. Goodwill PW,
    3. Conolly SM

    . The X-space formulation of the magnetic particle imaging process: 1-D signal, resolution, bandwidth, SNR, SAR, and magnetostimulation. IEEE Trans Med Imaging 2010;29:1851–59 doi:10.1109/TMI.2010.2052284 pmid:20529726

    CrossRefPubMed
13. 13.↵
    2. Goodwill PW,
    3. Conolly SM

    . Multidimensional X-space magnetic particle imaging. IEEE Trans Med 2011;30:1581–90 doi:10.1109/TMI.2011.2125982

    CrossRef
14. 14.↵
    2. Arami H,
    3. Teeman E,
    4. Troksa A, et al

    . Tomographic magnetic particle imaging of cancer targeted nanoparticles. Nanoscale 2017;9:18723–30 doi:10.1039/c7nr05502a pmid:29165498

    CrossRefPubMed
15. 15.↵
    2. Knopp T,
    3. Biederer S,
    4. Sattel TF, et al

    . Prediction of the spatial resolution of magnetic particle imaging using the modulation transfer function of the imaging process. IEEE Trans Med Imaging 2011;30:1284–92 doi:10.1109/TMI.2011.2113188 pmid:21317081

    CrossRefPubMed
16. 16.↵
    2. Moses WW

    . Fundamental limits of spatial resolution in PET. Nucl Instrum Methods Phys Res A 2011;648(Supplement 1):S236–40 doi:10.1016/j.nima.2010.11.092 pmid:21804677

    CrossRefPubMed
17. 17.↵
    2. Bailey DL,
    3. Willowson KP

    . An evidence-based review of quantitative SPECT imaging and potential clinical applications. J Nucl Med 2013;54:83–89 doi:10.2967/jnumed.112.111476 pmid:23283563

    Abstract/FREE Full Text
18. 18.↵
    2. Zheng B,
    3. Vazin T,
    4. Goodwill PW, et al

    . Magnetic particle imaging tracks the long-term fate of in vivo neural cell implants with high image contrast. Sci Rep 2015;5:14055 doi:10.1038/srep14055 pmid:26358296

    CrossRefPubMed
19. 19.↵
    2. Wintermark M,
    3. Sesay M,
    4. Barbier E, et al

    . Comparative overview of brain perfusion imaging techniques. Stroke 2005;36:83–99 doi:10.1161/01.STR.0000177884.72657.8b pmid:16100027

    Abstract/FREE Full Text
20. 20.↵
    2. Saritas EU,
    3. Goodwill PW,
    4. Croft LR, et al

    . Magnetic particle imaging (MPI) for NMR and MRI researchers. J Magn Reson 2013;229:116–26 doi:10.1016/j.jmr.2012.11.029 pmid:23305842

    CrossRefPubMed
21. 21.
    2. Knopp T,
    3. Buzug TM

    . Magnetic Particle Imaging: An Introduction to Imaging Principles and Scanner Instrumentation. Heidelberg: Springer-Verlag; 2012
22. 22.
    2. Kherlopian AR,
    3. Song T,
    4. Duan Q, et al

    . A review of imaging techniques for systems biology. BMC Syst Biol 2008;2:74 doi:10.1186/1752-0509-2-74 pmid:18700030

    CrossRefPubMed
23. 23.
    2. Weissleder R

    . Scaling down imaging: molecular mapping of cancer in mice. Nat Rev Cancer 2002;2:11–18 doi:10.1038/nrc701 pmid:11902581

    CrossRefPubMedWeb of Science
24. 24.
    2. Cox B,
    3. Beard P

    . Imaging techniques: super-resolution ultrasound. Nature 2015;527:451–52 doi:10.1038/527451a pmid:26607538

    CrossRefPubMed
25. 25.
    2. Goodwill PW,
    3. Saritas EU,
    4. Croft LR, et al

    . X-space MPI: magnetic nanoparticles for safe medical imaging. Adv Mater 2012;24:3870–77 doi:10.1002/adma.201200221 pmid:22988557

    CrossRefPubMed
26. 26.↵
    2. Khandhar AP,
    3. Keselman P,
    4. Kemp SJ, et al

    . Evaluation of PEG-coated iron oxide nanoparticles as blood pool tracers for preclinical magnetic particle imaging. Nanoscale 2017;9:1299–306 doi:10.1039/C6NR08468K pmid:28059427

    CrossRefPubMed
27. 27.↵
    2. Yu EY,
    3. Chandrasekharan P,
    4. Berzon R, et al

    . Magnetic particle imaging for highly sensitive, quantitative, and safe in vivo gut bleed detection in a murine model. ACS Nano 2017;11:12067–76 doi:10.1021/acsnano.7b04844 pmid:29165995

    CrossRefPubMed
28. 28.↵
    2. Orendorff R,
    3. Peck AJ,
    4. Zheng B

    . First in vivo traumatic brain injury imaging via magnetic particle imaging. Phys Med Biol 2017;62:3501–09 doi:10.1088/1361-6560/aa52ad pmid:28378708

    CrossRefPubMed
29. 29.↵
    2. Weizenecker J,
    3. Gleich B,
    4. Rahmer J, et al

    . Three-dimensional real-time in vivo magnetic particle imaging. Phys Med Biol 2009;54:L1–10 doi:10.1088/0031-9155/54/5/L01 pmid:19204385

    CrossRefPubMed
30. 30.↵
    2. Haegele J,
    3. Biederer S,
    4. Wojtczyk H, et al

    . Toward cardiovascular interventions guided by magnetic particle imaging: first instrument characterization. Magn Reson Med 2013;69:1761–67 doi:10.1002/mrm.24421 pmid:22829518

    CrossRefPubMed
31. 31.↵
    2. Haegele J,
    3. Rahmer J,
    4. Gleich B, et al

    . Magnetic particle imaging: visualization of instruments for cardiovascular intervention. Radiology 2012;265:933–38 doi:10.1148/radiol.12120424 pmid:22996744

    CrossRefPubMed
32. 32.↵
    2. Yu EY,
    3. Bishop M,
    4. Zheng B, et al

    . Magnetic particle imaging: a novel in vivo imaging platform for cancer detection. Nano Lett 2017;17:1648–54 doi:10.1021/acs.nanolett.6b04865 pmid:28206771

    CrossRefPubMed
33. 33.↵
    2. Ryken TC,
    3. Aygun N,
    4. Morris J, et al

    . The role of imaging in the management of progressive glioblastoma: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2014;118:435–60 doi:10.1007/s11060-013-1330-0 pmid:24715656

    CrossRefPubMed
34. 34.↵
    2. Verma N,
    3. Cowperthwaite MC,
    4. Burnett MG, et al

    . Differentiating tumor recurrence from treatment necrosis: a review of neuro-oncologic imaging strategies. Neuro Oncol 2013;15:515–34 doi:10.1093/neuonc/nos307 pmid:23325863

    CrossRefPubMed
35. 35.↵
    2. Langen KJ,
    3. Watts C

    . Neuro-oncology: amino acid PET for brain tumours—ready for the clinic? Nat Rev Neurol 2016;12:375–76 doi:10.1038/nrneurol.2016.80 pmid:27282652

    CrossRefPubMed
36. 36.↵
    2. Maeda H,
    3. Wu J,
    4. Sawa T, et al

    . Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 2000;65:271–84 doi:10.1016/S0168-3659(99)00248-5 pmid:10699287

    CrossRefPubMedWeb of Science
37. 37.↵
    2. Béduneau A,
    3. Saulnier P,
    4. Benoit JP

    . Active targeting of brain tumors using nanocarriers. Biomaterials 2007;28:4947–67 doi:10.1016/j.biomaterials.2007.06.011 pmid:17716726

    CrossRefPubMedWeb of Science
38. 38.↵
    2. Cheng Y,
    3. Morshed RA,
    4. Auffinger B, et al

    . Multifunctional nanoparticles for brain tumor imaging and therapy. Adv Drug Deliv Rev 2014;66:42–57 doi:10.1016/j.addr.2013.09.006 pmid:24060923

    CrossRefPubMed
39. 39.↵
    2. Murase K,
    3. Aoki M,
    4. Banura N, et al

    . Usefulness of magnetic particle imaging for predicting the therapeutic effect of magnetic hyperthermia. Open Journal of Medical Imaging 2015;5:85–99 doi:10.4236/ojmi.2015.52013

    CrossRef
40. 40.↵
    2. Murase K,
    3. Mimura A,
    4. Banura N, et al

    . Visualization of magnetic nanofibers using magnetic particle imaging. Open Journal of Medical Imaging 2015;05:56–65 doi:10.4236/ojmi.2015.52009

    CrossRef
41. 41.↵
    2. Eggenhofer E,
    3. Luk F,
    4. Dahlke MH, et al

    . The life and fate of mesenchymal stem cells. Front Immunol 2014;5:148 doi:10.3389/fimmu.2014.00148 pmid:24904568

    CrossRefPubMed
42. 42.↵
    2. Wu Y,
    3. Zhao RC

    . The role of chemokines in mesenchymal stem cell homing to myocardium. Stem Cell Rev 2012;8:243–50 doi:10.1007/s12015-011-9293-z pmid:1706142

    CrossRefPubMedWeb of Science
43. 43.↵
    2. Harting MT,
    3. Jimenez F,
    4. Xue H, et al

    . Intravenous mesenchymal stem cell therapy for traumatic brain injury. J Neurosurg 2009;110:1189–97 doi:10.3171/2008.9.JNS08158.Intravenous pmid:19301973

    CrossRefPubMedWeb of Science
44. 44.↵
    2. Lüdtke-Buzug K,
    3. Rapoport D

    . Characterization of iron-oxide loaded adult stem cells for magnetic particle imaging in targeted cancer therapy. AIP Conf Proc 2010;1311:244–48
45. 45.↵
    2. Antonelli A,
    3. Sfara C,
    4. Rahmer J, et al

    . Red blood cells as carriers in magnetic particle imaging. Biomed Tech (Berl) 2013;58:517–25 doi:10.1515/bmt-2012-0065 pmid:23839809

    CrossRefPubMed
46. 46.↵
    2. Markov DE,
    3. Boeve H,
    4. Gleich B, et al

    . Human erythrocytes as nanoparticle carriers for magnetic particle imaging. Phys Med Biol 2010;55:6461–73 doi:10.1088/0031-9155/55/21/008 pmid:20959685

    CrossRefPubMed
47. 47.↵
    2. Haegele J,
    3. Duschka R,
    4. Graeser M, et al

    . Magnetic particle imaging: kinetics of the intravascular signal in vivo. Int J Nanomedicine 2014;9:4203–09 doi:10.2147/IJN.S49976 pmid:25214784

    CrossRefPubMed
48. 48.↵
    2. de Vries IJ,
    3. Lesterhuis WJ,
    4. Barentsz JO, et al

    . Magnetic resonance tracking of dendritic cells in melanoma patients for monitoring of cellular therapy. Nat Biotechnol 2005;23:1407–13 doi:10.1038/nbt1154 pmid:16258544

    CrossRefPubMedWeb of Science
49. 49.↵
    2. Lefevre S,
    3. Ruimy D,
    4. Jehl F, et al

    . Septic arthritis: monitoring with USPIO-enhanced macrophage MR imaging. Radiology 2011;258:722–28 doi:10.1148/radiol.10101272 pmid:21339348

    CrossRefPubMed
50. 50.↵
    2. Lutz AM,
    3. Weishaupt D,
    4. Persohn E, et al

    . Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics. Radiology 2005;234:765–75 doi:10.1148/radiol.2343031172 pmid:15665219

    CrossRefPubMed
51. 51.↵
    2. Ruehm SG,
    3. Corot C,
    4. Vogt P, et al

    . Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 2001;103:415–22 doi:10.1161/01.CIR.103.3.415 pmid:11157694

    Abstract/FREE Full Text
52. 52.↵
    2. Sigovan M,
    3. Boussel L,
    4. Sulaiman A, et al

    . Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model. Radiology 2009;252:401–09 doi:10.1148/radiol.2522081484 pmid:19703881

    CrossRefPubMedWeb of Science
53. 53.↵
    2. Metz S,
    3. Beer AJ,
    4. Settles M, et al

    . Characterization of carotid artery plaques with USPIO-enhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability. Int J Cardiovasc Imaging 2011;27:901–12 doi:10.1007/s10554-010-9736-7 pmid:20972832

    CrossRefPubMed
54. 54.↵
    2. McAteer MA,
    3. Sibson NR,
    4. von Zur Muhlen C, et al

    . In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide. Nat Med 2007;13:1253–58 doi:10.1038/nm1631 pmid:17891147

    CrossRefPubMedWeb of Science
55. 55.↵
    2. Wang YX

    . Superparamagnetic iron oxide based MRI contrast agents: current status of clinical application. Quant Imaging Med Surg 2011;1:35–40 doi:10.3978/j.issn.2223-4292.2011.08.03 pmid:23256052

    CrossRefPubMed
56. 56.↵
    2. Panagiotopoulos N,
    3. Duschka RL,
    4. Ahlborg M, et al

    . Magnetic particle imaging: current developments and future directions. Int J Nanomedicine 2015;10:3097–114 doi:10.2147/IJN.S70488 pmid:25960650

    CrossRefPubMed
57. 57.↵
    2. Wang YX,
    3. Hussain SM,
    4. Krestin GP

    . Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging. Eur Radiol 2001;11:2319–31 doi:10.1007/s003300100908 pmid:11702180

    CrossRefPubMedWeb of Science
58. 58.↵
    2. Bonnemain B

    . Superparamagnetic agents in magnetic resonance imaging: physicochemical characteristics and clinical applications—a review. J Drug Target 1998;6:167–74 doi:10.3109/10611869808997890 pmid:9888302

    CrossRefPubMedWeb of Science
59. 59.↵
    2. Sun C,
    3. Lee JS,
    4. Zhang M

    . Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev 2008;60:1252–65 doi:10.1016/j.addr.2008.03.018 pmid:18558452

    CrossRefPubMedWeb of Science
60. 60.↵
    2. Pablico-Lansigan MH,
    3. Situ SF,
    4. Samia AC

    . Magnetic particle imaging: advancements and perspectives for real-time in vivo monitoring and image-guided therapy. Nanoscale 2013;5:4040–55 doi:10.1039/c3nr00544e pmid:23538400

    CrossRefPubMed
61. 61.↵
    2. Bauer LM,
    3. Situ SF,
    4. Griswold MA, et al

    . Magnetic particle imaging tracers: state-of-the-art and future directions. J Phys Chem Lett 2015;6:2509–17 doi:10.1021/acs.jpclett.5b00610 pmid:26266727

    CrossRefPubMed
62. 62.↵
    2. Reimer P,
    3. Tombach B

    . Hepatic MRI with SPIO: detection and characterization of focal liver lesions. Eur Radiol 1998;1204:1198–204 doi:10.1007/s003300050535 pmid:9724439

    CrossRefPubMed
63. 63.↵
    2. Reimer P,
    3. Balzer T

    . Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver—properties, clinical development, and applications. Eur Radiol 2003;13:1266–76 doi:10.1007/s00330-002-1721-7 pmid:12764641

    CrossRefPubMed
64. 64.↵
    2. Eberbeck D,
    3. Wiekhorst F,
    4. Wagner S, et al

    . How the size distribution of magnetic nanoparticles determines their magnetic particle imaging performance. Appl Phys Lett 2011;98:182502 doi:10.1063/1.3586776

    CrossRef
65. 65.↵
    2. Khandhar AP,
    3. Ferguson RM,
    4. Arami H, et al

    . Tuning surface coatings of optimized magnetite nanoparticle tracers for in vivo magnetic particle imaging. IEEE Trans Magn 2015;51:395–401 doi:10.1109/TMAG.2014.2321096

    CrossRef
66. 66.↵
    2. Arami H,
    3. Ferguson RM,
    4. Khandhar AP, et al

    . Size-dependent ferrohydrodynamic relaxometry of magnetic particle imaging tracers in different environments. Med Phys 2013;40:071904 doi:10.1118/1.4810962 pmid:23822441

    CrossRefPubMed
67. 67.↵
    2. Ferguson RM,
    3. Minard KR,
    4. Khandhar AP, et al

    . Optimizing magnetite nanoparticles for mass sensitivity in magnetic particle imaging. Med Phys 2011;38:1619–26 doi:10.1118/1.3554646 pmid:21520874

    CrossRefPubMed
68. 68.↵
    2. Ferguson RM,
    3. Minard KR,
    4. Krishnan KM

    . Optimization of nanoparticle core size for magnetic particle imaging. J Magn Magn Mater 2009;321:1548–51 doi:10.1016/j.jmmm.2009.02.083 pmid:19606261

    CrossRefPubMed
69. 69.↵
    2. Ferguson RM,
    3. Khandhar AP,
    4. Krishnan KM

    . Tracer design for magnetic particle imaging (invited). J Appl Phys 2012;07B318 doi:10.1063/1.3676053

    CrossRef
70. 70.↵
    2. Arami H,
    3. Krishnan KM

    . Highly stable amine functionalized iron oxide nanoparticles designed for magnetic particle imaging (MPI). IEEE Trans Magn 2013;49:3500–03 doi:10.1109/TMAG.2013.2245110

    CrossRef
71. 71.↵
    2. Ludwig F,
    3. Wawrzik T,
    4. Yoshida T, et al

    . Optimization of magnetic nanoparticles for magnetic particle imaging. IEEE Trans Magn 2012;48:3780–83 doi:10.1109/TMAG.2012.2197601

    CrossRef
72. 72.↵
    2. Starmans LW,
    3. Burdinski D,
    4. Haex NP, et al

    . Iron oxide nanoparticle-micelles (ION-micelles) for sensitive (molecular) magnetic particle imaging and magnetic resonance imaging. PLoS One 2013;8:e57335 doi:10.1371/journal.pone.0057335 pmid:23437371

    CrossRefPubMed
73. 73.↵
    2. Starmans LW,
    3. Moonen RP,
    4. Aussems-Custers E, et al

    . Evaluation of iron oxide nanoparticle micelles for magnetic particle imaging (MPI) of thrombosis. PLoS One 2015;10:e0119257 doi:10.1371/journal.pone.0119257 pmid:25746677

    CrossRefPubMed
74. 74.↵
    2. Ishihara Y,
    3. Honma T,
    4. Nohara S, et al

    . Evaluation of magnetic nanoparticle samples made from biocompatible ferucarbotran by time-correlation magnetic particle imaging reconstruction method. BMC Med Imaging 2013;13:15 doi:10.1186/1471-2342-13-15 pmid:23734917

    CrossRefPubMed
75. 75.↵
    2. Lindemann A,
    3. Lüdtke-Buzug K,
    4. Fräderich BM, et al

    . Biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells. Int J Nanomedicine 2014;9:5025–40 doi:10.2147/IJN.S63873 pmid:25378928

    CrossRefPubMed
76. 76.↵
    2. Kehagias DT,
    3. Gouliamos AD,
    4. Smyrniotis V, et al

    . Diagnostic efficacy and safety of MRI of the liver with superparamagnetic iron oxide particles (SH U 555 A). J Magn Reson Imaging 2001;14:595–601 doi:10.1002/jmri.1224 pmid:11747012

    CrossRefPubMed
77. 77.↵
    2. Bernd H,
    3. De Kerviler E,
    4. Gaillard S, et al

    . Safety and tolerability of ultrasmall superparamagnetic iron oxide contrast agent: comprehensive analysis of a clinical development program. Invest Radiol 2009;44:336–42 doi:10.1097/RLI.0b013e3181a0068b pmid:19661843

    CrossRefPubMed
78. 78.↵
    2. Singh A,
    3. Patel T,
    4. Hertel J, et al

    . Safety of ferumoxytol in patients with anemia and CKD. Am J Kidney Dis 2008;52:907–15 doi:10.1053/j.ajkd.2008.08.001 pmid:18824288

    CrossRefPubMedWeb of Science
79. 79.↵
    2. Saritas EU,
    3. Goodwill PW,
    4. Zhang GZ, et al

    . Magnetostimulation limits in magnetic particle imaging. IEEE Trans Med Imaging 2013;32:1600–10 doi:10.1109/TMI.2013.2260764 pmid:23649181

    CrossRefPubMed
80. 80.↵
    1. Buzug TM,
    2. Knopp T

    2. Saritas EU,
    3. Goodwill PW,
    4. Zhang GZ, et al

    . Safety limits for human-size magnetic particle imaging systems. In: Buzug TM, Knopp T, eds. Magnetic Particle Imaging. Berlin: Springer-Verlag; 2011:325–30
81. 81.↵
    2. Schmale I,
    3. Gleich B,
    4. Rahmer J, et al

    . MPI safety in the view of MRI safety standards. IEEE Trans Mag 2015;51:1–4 doi:10.1109/TMAG.2014.2322940

    CrossRefPubMed
82. 82.↵
    2. Duschka RL,
    3. Wojtczyk H,
    4. Panagiotopoulos N, et al

    . Safety measurements for heating of instruments for cardiovascular interventions in magnetic particle imaging (MPI): first experiences. J Healthc Eng 2014;5:79–93 doi:10.1260/2040-2295.5.1.79 pmid:24691388

    CrossRefPubMed
83. 83.↵
    2. Croft LR,
    3. Goodwill PW,
    4. Konkle JJ, et al

    . Low drive field amplitude for improved image resolution in magnetic particle imaging. Med Phys 2016;43:424 doi:10.1118/1.4938097 pmid:26745935

    CrossRefPubMed